Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Boyle

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
European Journal of Clinical Pharmacology|July 29, 1999
The pharmacokinetics of carvedilol and its metabolites after single and multiple dose oral administration in patients with hypertension and renal insufficiencyT W Gehr, D M Tenero, D A Boyle, et al.
Pharmacotherapy|September 1, 1994
Effects of long-term oral carvedilol on the steady-state pharmacokinetics of oral digoxin in patients with mild to moderate hypertensionD P Wermeling, C J Field, D A Smith, et al.
Journal of Pharmaceutical Sciences|September 1, 1988
Absolute bioavailability and dose proportionality of betaxolol in normal healthy subjectsT M Ludden, D A Boyle, D Gieseker, et al.
Journal of Clinical Pharmacology|August 6, 1999
The effect of low-dose cimetidine (200 mg twice daily) on the pharmacokinetics of theophyllineD E Nix, R A Di Cicco, A K Miller, et al.
The Annals of Pharmacotherapy|April 9, 1998
Effect of ranitidine on the pharmacokinetics of orally administered eprosartan, an angiotensin II antagonist, in healthy male volunteersD M Tenero, D E Martin, B E Ilson, et al.
Clinical Pharmacology and Therapeutics|April 1, 1991
The effect of food on pharmacokinetics and pharmacodynamics of fenoldopam in class III heart failureD G Blanchett, J A Green, A Nara, et al.
Pediatric Blood & Cancer|April 14, 2011
Argatroban therapy in pediatric patients requiring nonheparin anticoagulation: an open-label, safety, efficacy, and pharmacokinetic studyG Young, L K Boshkov, J E Sullivan, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
European Journal of Clinical Pharmacology|July 29, 1999
The pharmacokinetics of carvedilol and its metabolites after single and multiple dose oral administration in patients with hypertension and renal insufficiencyT W Gehr, D M Tenero, D A Boyle, et al.
Pharmacotherapy|September 1, 1994
Effects of long-term oral carvedilol on the steady-state pharmacokinetics of oral digoxin in patients with mild to moderate hypertensionD P Wermeling, C J Field, D A Smith, et al.
Journal of Pharmaceutical Sciences|September 1, 1988
Absolute bioavailability and dose proportionality of betaxolol in normal healthy subjectsT M Ludden, D A Boyle, D Gieseker, et al.
Journal of Clinical Pharmacology|August 6, 1999
The effect of low-dose cimetidine (200 mg twice daily) on the pharmacokinetics of theophyllineD E Nix, R A Di Cicco, A K Miller, et al.
The Annals of Pharmacotherapy|April 9, 1998
Effect of ranitidine on the pharmacokinetics of orally administered eprosartan, an angiotensin II antagonist, in healthy male volunteersD M Tenero, D E Martin, B E Ilson, et al.
Clinical Pharmacology and Therapeutics|April 1, 1991
The effect of food on pharmacokinetics and pharmacodynamics of fenoldopam in class III heart failureD G Blanchett, J A Green, A Nara, et al.
Pediatric Blood & Cancer|April 14, 2011
Argatroban therapy in pediatric patients requiring nonheparin anticoagulation: an open-label, safety, efficacy, and pharmacokinetic studyG Young, L K Boshkov, J E Sullivan, et al.
Pageof 2